Victoza®, the first once-daily human glucagon-like peptide-1 (GLP-1) analogue that regulates blood sugar in a glucose-dependent manner, is now available for people with type 2 diabetes in the UK.
31 July, 2009
Scientists have developed a new drug that can reduce the growth of tumours in mice by up to 98 per cent, according to a study published in Molecular Cancer Therapeutics recently.
27 July, 2009
Cancer Research Technology, Merck Serono, Cancer Research UK, Cardiff University and The Institute of Cancer Research are set to begin a new research collaboration that will provide substantial investment in research on the WNT signalling pathway in the hope of finding new drug targets.
27 July, 2009
Prostate cancer has overtaken lung cancer to become the most common cancer in men, affecting more than 35,000 men every year in the UK. Now, new UK research has confirmed that the cancer drug abiraterone provides a significant benefit for up to two-thirds of men with advanced and aggressive prostate cancer, according to a study published recently in the Journal of Clinical Oncology.
27 July, 2009
New data presented recently at the British Society for Allergy and Clinical Immunology (BSACI) annual meeting have demonstrated that a new tablet treatment, Grazax®, is the first tablet treatment to provide sustained disease control in patients with grass pollen rhinoconjunctivitis (hay fever) after the treatment period ended.
21 July, 2009
Parkinson's disease is a degenerative brain disorder that is triggered by death or degeneration of nerve cells in a part of the brain called substantia nigra. This brain region is essential in maintaining normal movement, so when the cells start to die off, patients lose the ability to properly execute and control movements.
21 July, 2009